A recent study investigated predictors of repeat participation in the NHS Bowel Cancer Screening Programme (BCSP). Most types of population-based cancer screening require repeat participation to be effective.
Guaiac fecal occult blood test (gFOBt) was performed as a biennial colorectal cancer-screening test in the BCSP in England for the age group of 60-74 years.
Colorectal Cancer Screening
Colorectal screening is done using tests to detect blood in stool, colonoscopy or sigmoidoscopy ordouble contrast barium enema or CT colonography.
Advertisement
A total of 62,081 participants were aged 60-64 years at the time of the first invitation were recruited for the study. The main outcome was repeat participation at their second or third invitation.
Behavioural measures derived from screening records included late return of the gFOBt kit, compliance with follow-up investigations and previous screening participation.
![Colorectal Cancer Screening with Colonoscopy]( "Colorectal Cancer Screening with Colonoscopy")
Colonoscopy is a widely used endoscopic procedure to screen individuals for colorectal cancer. It is very sensitive in detecting colorectal cancers.
Other potential predictors of repeat participation included results of individual test kit analysis (normal, weak positive, strong positive, spoilt) and the definitive result of the gFOBt screening episode (normal or abnormal). Age, sex and socioeconomic deprivation were also recorded.
Overall repeat uptake was 82% in the second and third invitations on an average. Late return of the test kit was consistently associated with lower uptake.
A definitive abnormal gFOBt result in the previous screening episode was a negative predictor of repeat uptake.
Weak positive and spoilt test kits were associated with lower repeat uptake, but were not consistently independent predictors in all invitation rounds or subgroups.
Among those with a definitive abnormal gFOBt result, noncompliance with follow-up in a previous screening episode was also associated with lower repeat uptake.
Behavioural markers and test results from previous screening episodes have been implicated in subsequent gFOBt uptake.
Source: Medindia
Colorectal Cancer Screening with Colonoscopy
Colonoscopy is a widely used endoscopic procedure to screen individuals for colorectal cancer. It is very sensitive in detecting colorectal cancers.
Advertisement
Other potential predictors of repeat participation included results of individual test kit analysis (normal, weak positive, strong positive, spoilt) and the definitive result of the gFOBt screening episode (normal or abnormal). Age, sex and socioeconomic deprivation were also recorded.
Overall repeat uptake was 82% in the second and third invitations on an average. Late return of the test kit was consistently associated with lower uptake.
A definitive abnormal gFOBt result in the previous screening episode was a negative predictor of repeat uptake.
Weak positive and spoilt test kits were associated with lower repeat uptake, but were not consistently independent predictors in all invitation rounds or subgroups.
Among those with a definitive abnormal gFOBt result, noncompliance with follow-up in a previous screening episode was also associated with lower repeat uptake.
Behavioural markers and test results from previous screening episodes have been implicated in subsequent gFOBt uptake.
Source: Medindia
Colo-rectal cancer - Management
Treatment for Colorectal Cancers may involve surgery,chemotherapy, radiation therapy or biological therapy. Some people require a combination of treatments.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The mechanism by which the kinases cause inflammation has been discovered by scientists.